CBUS
NASDAQ
Biotechnology
$1.36
USD
+$0.02 (+1.49%)
Last close
Market Cap:
$103.81M
Volume:
279.7K
Previous Close
$1.34
Day Range
$1.27 - $1.43
52 Week Range
$1.09 - $4.19
Average Volume (10 Days)
310K
P/E Ratio
0.00
Dividend Yield
0.00%
Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 118 full-time employees. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
CEO
Dr. Peter Beetham
Headquaters
San Diego, CALIFORNIA, US
Founded
2017
Employees
118
ANIX
Anixa Biosciences Inc
$2.79
+6.5%
BDTX
Black Diamond Therapeutics Inc
$1.71
+0.6%